Company
United StatesAmitabha Mazumder, M.D., Pasadena, CA – FDA Inspections
Inspection records and compliance data for Amitabha Mazumder, M.D. in Pasadena, CA. 1 FDA inspection on record, last inspected April 05, 2024.
Company Profile
This profile covers Amitabha Mazumder, M.D. based in Pasadena, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected April 5, 2024.
Most cited issue areas
- FD-1572, protocol compliance1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 5, 2024 | VAI | Human Drugs · Bioresearch Monitoring | 1235523 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Scilex Pharmaceuticals Inc.
Comparative Biosciences, Inc
McKesson Corporation Headquarters
Molecular Imaging Program at Stanford
Ascendis Pharma LLC
Protagonist Therapeutics Inc
David M. Scarpino, M.D.
Zev Wainberg, M.D.
Chamindra Laverty
Stanford University School of Medicine Radioactive Drug Research Committee
Company Information
Name
Amitabha Mazumder, M.D.
FEI Number
3003439545
Address
The Oncology Institute Of Hope And Innovation, 50 Bellefontaine St Ste 401, Pasadena, CA 91105-3132, United States
Country
United States
ID: cf6e20fc-a241-490a-96ec-954dea17b9e7